Exparel
402-C-319
Phase 3 small_molecule completed
Quick answer
Exparel for Postoperative Pain Management is a Phase 3 program (small_molecule) at Pacira BioSciences with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Pacira BioSciences
- Indication
- Postoperative Pain Management
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed